FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults
http://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-antiviral-treatment-covid-19-adults

http://www.fda.gov/medical-devices/medical-device-recalls/sd-biosensor-inc-recalls-certain-pilot-covid-19-home-tests-potential-bacteria-contamination

http://www.fda.gov/medical-devices/medical-device-recalls/draeger-medical-recalls-seattle-pap-plus-and-breathing-circuitanesthesia-kits-risk-loose-or-detached

FDA Approves New Treatment for Pneumonia Caused by Certain Difficult-to-Treat Bacteria
http://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-pneumonia-caused-certain-difficult-treat-bacteria

FDA Roundup: May 23, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-23-2023

FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
http://www.fda.gov/news-events/press-announcements/fda-approves-new-buprenorphine-treatment-option-opioid-use-disorder

FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose
http://www.fda.gov/news-events/press-announcements/fda-approves-prescription-nasal-spray-reverse-opioid-overdose

http://www.fda.gov/medical-devices/medical-device-recalls/icu-medical-recalls-replacement-batteries-plum-360-plum-and-plum-a3-infusion-systems-due-diminished

FDA Roundup: May 19, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-19-2023

FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
http://www.fda.gov/news-events/press-announcements/fda-approves-first-topical-gene-therapy-treatment-wounds-patients-dystrophic-epidermolysis-bullosa